Investigating the Role of Drug Tolerant Persisters in Driving Colorectal Cancer Metastasis.
研究耐药性持续存在在驱动结直肠癌转移中的作用。
基本信息
- 批准号:491461
- 负责人:
- 金额:$ 19.67万
- 依托单位:
- 依托单位国家:加拿大
- 项目类别:Fellowship Programs
- 财政年份:2023
- 资助国家:加拿大
- 起止时间:2023-05-01 至 2026-05-01
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Despite the strides made in scientific research in the last 20 years, there has been minimal improvement in the 5-year survival rate (~65%) of colorectal cancer (CRC) patients. As the third leading cause of cancer-related deaths in North America, CRC pati
尽管在过去的20年里,科学研究取得了长足的进步,但结直肠癌(CRC)患者的5年生存率(~65%)的改善却微乎其微。在北美,结直肠癌是导致癌症相关死亡的第三大原因
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rehman Sumaiyah其他文献
Rehman Sumaiyah的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
3D Engineered Model of Microscopic Colorectal Cancer Liver Metastasis for Adjuvant Chemotherapy Screens
用于辅助化疗筛选的显微结直肠癌肝转移 3D 工程模型
- 批准号:
10556192 - 财政年份:2023
- 资助金额:
$ 19.67万 - 项目类别:
Understanding the effect of chemotherapy on tumour heterogeneity and metastatic ability in colorectal cancer
了解化疗对结直肠癌肿瘤异质性和转移能力的影响
- 批准号:
2619836 - 财政年份:2021
- 资助金额:
$ 19.67万 - 项目类别:
Studentship
Circulating Tumour DNA Analysis Informing Adjuvant Chemotherapy in Stage III Colorectal Cancer: A Multicentre Phase II/III Randomised Controlled Trial (DYNAMIC-III)
循环肿瘤 DNA 分析为 III 期结直肠癌辅助化疗提供信息:多中心 II/III 期随机对照试验 (DYNAMIC-III)
- 批准号:
443988 - 财政年份:2021
- 资助金额:
$ 19.67万 - 项目类别:
Operating Grants
The possibility of urinary circulating tumor DNA predicting the effect of chemotherapy and recurrence risk after curative resection in colorectal cancer
尿循环肿瘤DNA预测结直肠癌化疗效果和根治性切除术后复发风险的可能性
- 批准号:
20K09020 - 财政年份:2020
- 资助金额:
$ 19.67万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Establishment of new selection system for adjuvant chemotherapy of colorectal cancer
结直肠癌辅助化疗新选择体系的建立
- 批准号:
20K09011 - 财政年份:2020
- 资助金额:
$ 19.67万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Drug delivery system in intraperitoneal chemotherapy for peritoneal dissemination of colorectal cancer
结直肠癌腹膜播散腹腔化疗中的给药系统
- 批准号:
19K09115 - 财政年份:2019
- 资助金额:
$ 19.67万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults with Colorectal Cancer: The M&M Study
老年结直肠癌患者的肌减少和化疗毒性机制:M
- 批准号:
9975790 - 财政年份:2018
- 资助金额:
$ 19.67万 - 项目类别:
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults with Colorectal Cancer: The M&M Study
老年结直肠癌患者的肌减少和化疗毒性机制:M
- 批准号:
10463649 - 财政年份:2018
- 资助金额:
$ 19.67万 - 项目类别:
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults with Colorectal Cancer: The M&M Study
老年结直肠癌患者的肌减少和化疗毒性机制:M
- 批准号:
10217047 - 财政年份:2018
- 资助金额:
$ 19.67万 - 项目类别:
A genetic analysis of the pharmacokinetic and pharmacodynamic pathways of cetuximab; to assess efficacy and toxicity outcomes in chemotherapy-refractory, metastatic colorectal cancer patients from the Canadian Cancer Trials Group CO.20 and CO.17 trials.
西妥昔单抗药代动力学和药效学途径的遗传分析;
- 批准号:
383355 - 财政年份:2017
- 资助金额:
$ 19.67万 - 项目类别:
Studentship Programs